Atlas Trials

The Use of Biomarkers to Predict CNS Involvement in Diffuse Large B-Cell Lymphoma: a Danish Nationwide Registry Study

Clinical trial NCT05169203 · COMPLETED

Trial details

NCT number
NCT05169203
Sponsor
Herlev Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
Diffuse Large B Cell LymphomaDiffuse Large B-Cell Lymphoma Cell of OriginDiffuse Large B-cell Lymphoma Recurrent
Start date
2014-01-01
Primary completion
2021-01-01
Enrollment
2969

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.